Effectors of the mammalian plasma membrane NADH-oxidoreductase system. Short-chain ubiquinone analogues as potent stimulators

Autor: François Vaillant, Ernst J. Wolvetang, Alfons Lawen, Gabrielle L. McMullen, Jari A Larm

Publikováno v: Monash University
Scopus-Elsevier

In the presence of effectors variations in the two recognized activities of the plasma membrane NADH-oxidoreductase system were studied in separate, specific in vitro assays. We report here that ubiquinone analogues that contain a short, less hydroph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20dc93bf63601b6059f77c0620974ad3
https://doi.org/10.1007/bf02110443

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Current treatment options for treating OPA1 -mutant dominant optic atrophy.

Autor: Ferro Desideri L; Clinica Oculistica, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, and IRCCS Ospedale Policlinico San Martino, Genoa, Italy. lorenzoferrodes@gmail.com., Traverso CE; Clinica Oculistica, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, and IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Iester M; Clinica Oculistica, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, and IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Publikováno v: Drugs of today (Barcelona, Spain : 1998) [Drugs Today (Barc)] 2022 Nov; Vol. 58 (11), pp. 547-552.